95 related articles for article (PubMed ID: 1511419)
1. Si(IV)-naphthalocyanine: modulation of its pharmacokinetic properties through the use of hydrophilic axial ligands.
Bellemo C; Jori G; Rihter BD; Kenney ME; Rodgers MA
Cancer Lett; 1992 Aug; 65(2):145-50. PubMed ID: 1511419
[TBL] [Abstract][Full Text] [Related]
2. Effect of axial ligation and delivery system on the tumour-localising and -photosensitising properties of Ge(IV)-octabutoxy-phthalocyanines.
Soncin M; Polo L; Reddi E; Jori G; Kenney ME; Cheng G; Rodgers MA
Br J Cancer; 1995 Apr; 71(4):727-32. PubMed ID: 7710936
[TBL] [Abstract][Full Text] [Related]
3. Controlled targeting of different subcellular sites by porphyrins in tumour-bearing mice.
Jori G; Reddi E; Cozzani I; Tomio L
Br J Cancer; 1986 May; 53(5):615-21. PubMed ID: 3718819
[TBL] [Abstract][Full Text] [Related]
4. Si(IV)-methoxyethylene-glycol-naphthalocyanine: synthesis and pharmacokinetic and photosensitizing properties in different tumour models.
Mantareva V; Shopova M; Spassova G; Wöhrle D; Muller S; Jori G; Ricchelli F
J Photochem Photobiol B; 1997 Oct; 40(3):258-62. PubMed ID: 9372614
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and phototherapeutic properties of axially substituted Si(IV)-tetradibenzobarreleno-octabutoxyphthalocyanines.
Soncin M; Busetti A; Reddi E; Jori G; Rither BD; Kenney ME; Rodgers MA
J Photochem Photobiol B; 1997 Sep; 40(2):163-7. PubMed ID: 9345784
[TBL] [Abstract][Full Text] [Related]
6. Tetra-n-propylporphycene as a tumour localizer: pharmacokinetic and phototherapeutic studies in mice.
Guardiano M; Biolo R; Jori G; Schaffner K
Cancer Lett; 1989 Jan; 44(1):1-6. PubMed ID: 2917338
[TBL] [Abstract][Full Text] [Related]
7. Liposome-delivered Si(IV)-naphthalocyanine as a photodynamic sensitiser for experimental tumours: pharmacokinetic and phototherapeutic studies.
Cuomo V; Jori G; Rihter B; Kenney ME; Rodgers MA
Br J Cancer; 1990 Dec; 62(6):966-70. PubMed ID: 2257228
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and tumour-photosensitizing properties of the cationic porphyrin meso-tetra(4N-methylpyridyl)porphine.
Villanueva A; Jori G
Cancer Lett; 1993 Sep; 73(1):59-64. PubMed ID: 8402599
[TBL] [Abstract][Full Text] [Related]
9. Laser-induced fluorescence in malignant and normal tissue in mice injected with two different carotenoporphyrins.
Nilsson H; Johansson J; Svanberg K; Svanberg S; Jori G; Reddi E; Segalla A; Gust D; Moore AL; Moore TA
Br J Cancer; 1994 Nov; 70(5):873-9. PubMed ID: 7947092
[TBL] [Abstract][Full Text] [Related]
10. Effect of chemical structure and hydrophobicity on the pharmacokinetic properties of porphycenes in tumour-bearing mice.
Segalla A; Fedeli F; Reddi E; Jori G; Cross A
Int J Cancer; 1997 Jul; 72(2):329-36. PubMed ID: 9219841
[TBL] [Abstract][Full Text] [Related]
11. Water-soluble aluminium phthalocyanine-polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice.
Brasseur N; Ouellet R; La Madeleine C; van Lier JE
Br J Cancer; 1999 Jul; 80(10):1533-41. PubMed ID: 10408394
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of benzoporphyrin derivative in malignant and host cell populations of the murine RIF tumor.
Korbelik M; Krosl G
Cancer Lett; 1995 Nov; 97(2):249-54. PubMed ID: 7497470
[TBL] [Abstract][Full Text] [Related]
13. Liposome- or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency.
Reddi E; Zhou C; Biolo R; Menegaldo E; Jori G
Br J Cancer; 1990 Mar; 61(3):407-11. PubMed ID: 2328207
[TBL] [Abstract][Full Text] [Related]
14. Liposome-delivered 131I-labelled Zn(II)-phthalocyanine as a radiodiagnostic agent for tumours.
Polo L; Segalla A; Jori G; Bocchiotti G; Verna G; Franceschini R; Mosca R; De Filippi PG
Cancer Lett; 1996 Dec; 109(1-2):57-61. PubMed ID: 9020903
[TBL] [Abstract][Full Text] [Related]
15. Tumour-localising and -photosensitising properties of a novel zinc(II) octadecylphthalocyanine.
Ometto C; Fabris C; Milanesi C; Jori G; Cook MJ; Russell DA
Br J Cancer; 1996 Dec; 74(12):1891-9. PubMed ID: 8980387
[TBL] [Abstract][Full Text] [Related]
16. Morphological aspects of an experimental tumour photosensitized with a meso-substituted cationic porphyrin.
Villanueva A; Caggiari L; Jori G; Milanesi C
J Photochem Photobiol B; 1994 Apr; 23(1):49-56. PubMed ID: 8021751
[TBL] [Abstract][Full Text] [Related]
17. Carotenoporphyrins as selective photodiagnostic agents for tumours.
Reddi E; Segalla A; Jori G; Kerrigan PK; Liddell PA; Moore AL; Moore TA; Gust D
Br J Cancer; 1994 Jan; 69(1):40-5. PubMed ID: 8286208
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic studies with zinc(II)-phthalocyanine in tumour-bearing mice.
Reddi E; Lo Castro G; Biolo R; Jori G
Br J Cancer; 1987 Nov; 56(5):597-600. PubMed ID: 3426922
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of 177Lu-DOTA-porphyrin conjugate: a potential agent for targeted tumor radiotherapy detection.
Bhadwal M; Mittal S; Das T; Sarma HD; Chakraborty S; Banerjee S; Pillai MR
Q J Nucl Med Mol Imaging; 2014 Jun; 58(2):224-33. PubMed ID: 24231798
[TBL] [Abstract][Full Text] [Related]
20. Tetraamido-substituted 2,3-naphthalocyanine zinc(II) complexes as phototherapeutic agents: synthesis, comparative photochemical and photobiological studies.
Müller S; Mantareva V; Stoichkova N; Kliesch H; Sobbi A; Wöhrle D; Shopova M
J Photochem Photobiol B; 1996 Sep; 35(3):167-74. PubMed ID: 8933723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
